Global Lymphedema Treatment Market Size, Trends & Growth Opportunity, by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) Region and forecast till 2027.
Report ID : QR1001383 | Industries : Healthcare | Published On :January 2022 | Page Count : 236Lymphedema Treatment Market
Lymphedema is most commonly associated with cancer treatments, which include removing lymph nodes through surgical procedures and/or radiation. For example, breast cancer survivors may develop lymphedema in their arm, hand, chest, head and/or neck. Patients presenting with cancer of the head and neck may develop swelling in the front of their neck or face. Gynaecological cancers can cause lymphedema in the leg, foot, abdomen and genitalia.
Lymphedema can also be present at birth or develop during adolescence due to the malformation of the lymphatic system. In addition, this disease can manifest as a complication from chronic venous insufficiency, infection, obesity, wounds and blood clots. Lymphedema is a lifelong, chronic and ongoing condition.
Drivers: Increasing cancer cases
It is reported that a majority of the lymphedema cases affect cancer patients. The condition can arise immediately after cancer surgery or radiation therapy. However, in certain cases, lymphedema is reported after months or years of cancer treatment. Thus, it is projected that the lymphedema treatment market will grow, parallelly, to the increasing prevalence of cancer.
Know more about this report: request for sample pages
Restraints: Need to change the compression garments at regular intervals.
There is a need to change the compression garments at regular intervals. Such garments have a lifespan of approximately six months. This creates reluctance in lymphedema patients to opt for such treatment options, thus, restricting market growth.
Impact of COVID-19
The COVID-19 pandemic impacted various industries, and authorities took preventative measures to control the spread of the virus. The implementation of lockdowns, travel restrictions, and closing down of meat-producing plants negatively affected the supply chain of the meat products. Many processing plants were shut down as they were identified as major outbreak spots for COVID-19 infections due to workers working near each other.
Segmentation By Disease Type:
On the basis of disease type, the market is segmented into cancer, cardiovascular disease, inflammatory diseases, and different diseases. By disease type, the cancer segment is expected to be the largest contributor to the lymphedema diagnostics market. The largest share of this segment can be attributed to the growing occurrence of most cancers-related lymphedema and growing focus approximately the early disease diagnosis. Lymphedema Treatment Market had a stable impact since due to the covid there were more no. Of Patients with critical health conditions.
Segmentation By Technology:
By technology, the lymphoscintigraphy phase is predicted to account for the biggest proportion throughout the forecast period. Based on technology, the lymphedema diagnostics market is segmented into lymphoscintigraphy, magnetic resonance imaging (MRI), ultrasound imaging, computed tomography (CT), X-ray lymphography, bioimpedance analysis, and near-infrared fluorescence imaging. The noninvasive nature and smooth reproducibility of this technology, and the reality that lymphoscintigraphy does now no longer adversely have an effect on the lymphatic vascular endothelium are a number of the important thing blessings helping the adoption of this technology.
Segmentation By End User:
By technology, the lymphoscintigraphy phase is predicted to account for the biggest proportion throughout the forecast period. Based on technology, the lymphedema diagnostics market is segmented into lymphoscintigraphy, magnetic resonance imaging (MRI), ultrasound imaging, computed tomography (CT), X-ray lymphography, bioimpedance analysis, and near-infrared fluorescence imaging. The noninvasive nature and smooth reproducibility of this technology, and the reality that lymphoscintigraphy does now no longer adversely have an effect on the lymphatic vascular endothelium are a number of the important thing blessings helping the adoption of this technology.
Segmentation by Region
Based on region, the NGS services market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is dominating the global lymphedema treatment market due to the launch of new products to treat the condition. North America is followed by Europe and Asia-Pacific in terms of dominance in the global Lymphedema Treatment market. In Asia-Pacific, the rising incidence of breast cancer is expected to drive the growth of the lymphedema treatment market during the forecast period.
Competitive Landscape:
GE Healthcare (US), Philips (Netherlands), and Siemens Healthineers (Germany), Shimadzu Corporation (Japan), and Stryker Corporation (US) dominated the lymphedema diagnostics market.
Industrial Development:
In August 2021, AIROS Medical, fist assist devices announced exclusive U.S. distribution deal for fist assist fa-1 compression device. This partnership will boost the market growth of the company.
In September 2020, Paul Hartmann formed partnerships with Apollo Hospitals Group in India and West China Hospital in to focus on the operation of wound care clinics and ambulances, medical training and products and services. This step helped the company to spread its wings in Asia Pacific market.
Market taxonomy
Lymphedema Diagnostics Market, by Technology
- X-ray Lymphography
- Lymphoscintigraphy
- Computed Tomography
- Ultrasound Imaging
- Magnetic Resonance Imaging
- Bioimpedance Analysis
- Near-infrared Fluorescence Imaging
- ICG Lymphography
- Fluorescein Sodium Microlymphangiography
Lymphedema Diagnostics Market, by Disease Type
- Cancer
- Cardiovascular Disease
- Inflammatory Diseases
- Other Diseases
Lymphedema Diagnostics Market, by End User
- Hospitals
- Diagnostic Centers
- Research & Academic Institutes
- Other End Users
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Lymphedema Treatment Market Outlook TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Lymphedema Treatment Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Lymphedema Treatment Market, By Disease Type
5.1 Y-o-Y Growth Comparison, By Disease Type
5.2 Lymphedema Treatment Market Share Analysis, By Disease Type
5.3 Lymphedema Treatment Market Size and Forecast, By Disease Type
5.3.1 Cancer
5.3.2 cardiovascular diseases
5.3.3 Inflammatory Diseases
5.3.4 Other Diseases
6 Lymphedema Treatment Market, By End-User
6.1 Y-o-Y Growth Comparison, By End-User
6.2 Lymphedema Treatment Market Share Analysis, By End-User
6.3 Lymphedema Treatment Market Size and Forecast, By End-User
6.3.1 Hospitals
6.3.2 Diagnostics Centres
6.3.3 Research & Academic Institutes
6.3.4 Other End Users
7 Lymphedema Treatment Market, By Technology
7.1 Y-o-Y Growth Comparison, By Technology
7.2 Lymphedema Treatment Market Share Analysis, By Technology
7.3 Lymphedema Treatment Market Size and Forecast, By Technology
7.3.1 X-ray Lymphography
7.3.2 Lymphoscintigraphy
7.3.3 Computed Tomography
7.3.4 Ultrasound Imaging
7.3.5 Magnetic Resonance Imaging
7.3.6 Bioimpedance Analysis
7.3.7 Near-infrared Fluorescence Imaging
7.3.8 Near-infrared Fluorescence Imaging
7.3.9 ICG Lymphography
7.3.10 Fluorescein Sodium Microlymphangiography
8 Lymphedema Treatment Market, By Region
8.1 Lymphedema Treatment Market Share Analysis, By Region
8.2 Lymphedema Treatment Market Size and Forecast, By Region
9 North America Lymphedema Treatment Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 North America Lymphedema Treatment Market Share Analysis, By Disease Type
9.3 North America Lymphedema Treatment Market Size and forecast, By End-User
9.4 North America Lymphedema Treatment Market Size and forecast, By Technology
9.5 North America Lymphedema Treatment Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Lymphedema Treatment Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Europe Lymphedema Treatment Market Share Analysis, By Disease Type
10.3 Europe Lymphedema Treatment Market Size and Forecast, By End-User
10.4 Europe Lymphedema Treatment Market Size and forecast., By Technology
10.5 Europe Lymphedema Treatment Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Lymphedema Treatment Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Asia Pacific Lymphedema Treatment Market Share Analysis, By Disease Type
11.3 Asia Pacific Lymphedema Treatment Market Size and Forecast, by End-User
11.4 Asia Pacific Lymphedema Treatment Market size and forecast, By Technology
11.6 Asia Pacific Lymphedema Treatment Market Size and Forecast, By Country
11.6.1 China
11.6.2 Japan
11.6.3 India
11.6.4 Rest of Asia Pacific
12 Latin America Lymphedema Treatment Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Latin America Lymphedema Treatment Market Share Analysis, By Disease Type
12.3 Latin America Lymphedema Treatment Market Size and Forecast, By End-User
12.4 Latin America Lymphedema Treatment Market Size and Forecast, By Technology
12.6 Latin America Lymphedema Treatment Market Size and Forecast, Country
12.6.1. Brazil
12.6.2. Rest of Latin America
13 Middle East Lymphedema Treatment Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Middle East Lymphedema Treatment Market Share Analysis, By Disease Type
13.3 Middle East Lymphedema Treatment Market Size and forecast, by End-User
13.4 Middle East Lymphedema Treatment Market Size and Forecast, by Technology
13.5 Middle East Lymphedema Treatment Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.2. UAE
13.5.3. Egypt
13.5.4 Kuwait
13.5.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 GE Healthcare (US)
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Philips (Netherlands)
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Siemens Healthineers (Germany)
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Shimadzu Corporation (Japan)
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Stryker Corporation (US)
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies